Global Panitumumab Market Size, Status and Forecast 2024-2031

Report ID: 917484 | Published Date: Sep 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Panitumumab Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 100 mg/5 mL single-dose vials
        1.2.3 400 mg/20 mLsingle-dose vials
    1.3 Market by Application
        1.3.1 Global Panitumumab Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Drug store
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Panitumumab Market Perspective (2016-2027)
    2.2 Panitumumab Growth Trends by Regions
        2.2.1 Panitumumab Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Panitumumab Historic Market Share by Regions (2016-2021)
        2.2.3 Panitumumab Forecasted Market Size by Regions (2022-2027)
    2.3 Panitumumab Industry Dynamic
        2.3.1 Panitumumab Market Trends
        2.3.2 Panitumumab Market Drivers
        2.3.3 Panitumumab Market Challenges
        2.3.4 Panitumumab Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Panitumumab Players by Revenue
        3.1.1 Global Top Panitumumab Players by Revenue (2016-2021)
        3.1.2 Global Panitumumab Revenue Market Share by Players (2016-2021)
    3.2 Global Panitumumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Panitumumab Revenue
    3.4 Global Panitumumab Market Concentration Ratio
        3.4.1 Global Panitumumab Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Panitumumab Revenue in 2020
    3.5 Panitumumab Key Players Head office and Area Served
    3.6 Key Players Panitumumab Product Solution and Service
    3.7 Date of Enter into Panitumumab Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Panitumumab Breakdown Data by Type
    4.1 Global Panitumumab Historic Market Size by Type (2016-2021)
    4.2 Global Panitumumab Forecasted Market Size by Type (2022-2027)

5 Panitumumab Breakdown Data by Application
    5.1 Global Panitumumab Historic Market Size by Application (2016-2021)
    5.2 Global Panitumumab Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Panitumumab Market Size (2016-2027)
    6.2 North America Panitumumab Market Size by Type
        6.2.1 North America Panitumumab Market Size by Type (2016-2021)
        6.2.2 North America Panitumumab Market Size by Type (2022-2027)
        6.2.3 North America Panitumumab Market Size by Type (2016-2027)
    6.3 North America Panitumumab Market Size by Application
        6.3.1 North America Panitumumab Market Size by Application (2016-2021)
        6.3.2 North America Panitumumab Market Size by Application (2022-2027)
        6.3.3 North America Panitumumab Market Size by Application (2016-2027)
    6.4 North America Panitumumab Market Size by Country
        6.4.1 North America Panitumumab Market Size by Country (2016-2021)
        6.4.2 North America Panitumumab Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Panitumumab Market Size (2016-2027)
    7.2 Europe Panitumumab Market Size by Type
        7.2.1 Europe Panitumumab Market Size by Type (2016-2021)
        7.2.2 Europe Panitumumab Market Size by Type (2022-2027)
        7.2.3 Europe Panitumumab Market Size by Type (2016-2027)
    7.3 Europe Panitumumab Market Size by Application
        7.3.1 Europe Panitumumab Market Size by Application (2016-2021)
        7.3.2 Europe Panitumumab Market Size by Application (2022-2027)
        7.3.3 Europe Panitumumab Market Size by Application (2016-2027)
    7.4 Europe Panitumumab Market Size by Country
        7.4.1 Europe Panitumumab Market Size by Country (2016-2021)
        7.4.2 Europe Panitumumab Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Panitumumab Market Size (2016-2027)
    8.2 Asia-Pacific Panitumumab Market Size by Type
        8.2.1 Asia-Pacific Panitumumab Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Panitumumab Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Panitumumab Market Size by Type (2016-2027)
    8.3 Asia-Pacific Panitumumab Market Size by Application
        8.3.1 Asia-Pacific Panitumumab Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Panitumumab Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Panitumumab Market Size by Application (2016-2027)
    8.4 Asia-Pacific Panitumumab Market Size by Region
        8.4.1 Asia-Pacific Panitumumab Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Panitumumab Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Panitumumab Market Size (2016-2027)
    9.2 Latin America Panitumumab Market Size by Type
        9.2.1 Latin America Panitumumab Market Size by Type (2016-2021)
        9.2.2 Latin America Panitumumab Market Size by Type (2022-2027)
        9.2.3 Latin America Panitumumab Market Size by Type (2016-2027)
    9.3 Latin America Panitumumab Market Size by Application
        9.3.1 Latin America Panitumumab Market Size by Application (2016-2021)
        9.3.2 Latin America Panitumumab Market Size by Application (2022-2027)
        9.3.3 Latin America Panitumumab Market Size by Application (2016-2027)
    9.4 Latin America Panitumumab Market Size by Country
        9.4.1 Latin America Panitumumab Market Size by Country (2016-2021)
        9.4.2 Latin America Panitumumab Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Panitumumab Market Size (2016-2027)
    10.2 Middle East & Africa Panitumumab Market Size by Type
        10.2.1 Middle East & Africa Panitumumab Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Panitumumab Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Panitumumab Market Size by Type (2016-2027)
    10.3 Middle East & Africa Panitumumab Market Size by Application
        10.3.1 Middle East & Africa Panitumumab Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Panitumumab Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Panitumumab Market Size by Application (2016-2027)
    10.4 Middle East & Africa Panitumumab Market Size by Country
        10.4.1 Middle East & Africa Panitumumab Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Panitumumab Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Details
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Panitumumab Introduction
        11.1.4 Amgen Revenue in Panitumumab Business (2016-2021)
        11.1.5 Amgen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Panitumumab Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of 100 mg/5 mL single-dose vials
    Table 3. Key Players of 400 mg/20 mLsingle-dose vials
    Table 4. Global Panitumumab Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Panitumumab Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Panitumumab Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Panitumumab Market Share by Regions (2016-2021)
    Table 8. Global Panitumumab Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Panitumumab Market Share by Regions (2022-2027)
    Table 10. Panitumumab Market Trends
    Table 11. Panitumumab Market Drivers
    Table 12. Panitumumab Market Challenges
    Table 13. Panitumumab Market Restraints
    Table 14. Global Panitumumab Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Panitumumab Market Share by Players (2016-2021)
    Table 16. Global Top Panitumumab Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Panitumumab as of 2020)
    Table 17. Ranking of Global Top Panitumumab Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Panitumumab Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Panitumumab Product Solution and Service
    Table 21. Date of Enter into Panitumumab Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Panitumumab Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Panitumumab Revenue Market Share by Type (2016-2021)
    Table 25. Global Panitumumab Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Panitumumab Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Panitumumab Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Panitumumab Revenue Market Share by Application (2016-2021)
    Table 29. Global Panitumumab Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Panitumumab Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Panitumumab Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Panitumumab Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Panitumumab Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Panitumumab Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Panitumumab Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Panitumumab Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Panitumumab Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Panitumumab Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Panitumumab Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Panitumumab Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Panitumumab Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Panitumumab Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Panitumumab Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Panitumumab Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Panitumumab Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Panitumumab Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Panitumumab Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Panitumumab Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Panitumumab Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Panitumumab Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Panitumumab Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Panitumumab Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Panitumumab Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Panitumumab Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Panitumumab Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Panitumumab Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Panitumumab Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Panitumumab Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Panitumumab Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Panitumumab Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Amgen Company Details
    Table 62. Amgen Business Overview
    Table 63. Amgen Panitumumab Product
    Table 64. Amgen Revenue in Panitumumab Business (2016-2021) & (US$ Million)
    Table 65. Amgen Recent Development
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Panitumumab Market Share by Type: 2020 VS 2027
    Figure 2. 100 mg/5 mL single-dose vials Features
    Figure 3. 400 mg/20 mLsingle-dose vials Features
    Figure 4. Global Panitumumab Market Share by Application: 2020 VS 2027
    Figure 5. Hospital Case Studies
    Figure 6. Drug store Case Studies
    Figure 7. Panitumumab Report Years Considered
    Figure 8. Global Panitumumab Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Panitumumab Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Panitumumab Market Share by Regions: 2020 VS 2027
    Figure 11. Global Panitumumab Market Share by Regions (2022-2027)
    Figure 12. Global Panitumumab Market Share by Players in 2020
    Figure 13. Global Top Panitumumab Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Panitumumab as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Panitumumab Revenue in 2020
    Figure 15. Global Panitumumab Revenue Market Share by Type (2016-2021)
    Figure 16. Global Panitumumab Revenue Market Share by Type (2022-2027)
    Figure 17. North America Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Panitumumab Market Share by Type (2016-2027)
    Figure 19. North America Panitumumab Market Share by Application (2016-2027)
    Figure 20. North America Panitumumab Market Share by Country (2016-2027)
    Figure 21. United States Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Panitumumab Market Share by Type (2016-2027)
    Figure 25. Europe Panitumumab Market Share by Application (2016-2027)
    Figure 26. Europe Panitumumab Market Share by Country (2016-2027)
    Figure 27. Germany Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Panitumumab Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Panitumumab Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Panitumumab Market Share by Region (2016-2027)
    Figure 37. China Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Panitumumab Market Share by Type (2016-2027)
    Figure 45. Latin America Panitumumab Market Share by Application (2016-2027)
    Figure 46. Latin America Panitumumab Market Share by Country (2016-2027)
    Figure 47. Mexico Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Panitumumab Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Panitumumab Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Panitumumab Market Share by Country (2016-2027)
    Figure 53. Turkey Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Amgen Revenue Growth Rate in Panitumumab Business (2016-2021)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Frequently Asked Questions
Panitumumab report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Panitumumab report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Panitumumab report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Decitabine Drug

Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inh ... Read More

Lubiprostone

Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in t ... Read More

Darunavir

Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication ... Read More

Anidulafungin

Anidulafungin (INN) (trade names Eraxis, Ecalta) is a semisynthetic echinocandin used as an antif ... Read More